series-b
Stage
1
Investors
About
Altesa BioSciences is a clinical-stage pharmaceutical company focused on developing antiviral medicines to treat respiratory infections, particularly targeting rhinovirus as the main cause of exacerbations in chronic lung diseases like COPD and asthma.
Explore Altesa BioSciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.